Cellectar Biosciences, Inc. (CLRB)
2.225
-0.04
(-1.55%)
USD |
NASDAQ |
Jun 11, 12:11
Cellectar Biosciences Price : 2.225 for June 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 10, 2026 | 2.36 | 2.390 | 2.25 | 2.26 | 111920.0 |
| Jun 09, 2026 | 2.50 | 2.559 | 2.33 | 2.36 | 192761.0 |
| Jun 08, 2026 | 2.61 | 2.702 | 2.470 | 2.51 | 153596.0 |
| Jun 05, 2026 | 2.72 | 2.755 | 2.52 | 2.59 | 183738.0 |
| Jun 04, 2026 | 2.64 | 2.80 | 2.60 | 2.75 | 137202.0 |
| Jun 03, 2026 | 2.79 | 2.79 | 2.57 | 2.60 | 243720.0 |
| Jun 02, 2026 | 2.96 | 2.96 | 2.74 | 2.74 | 241266.0 |
| Jun 01, 2026 | 3.11 | 3.14 | 2.97 | 2.97 | 151523.0 |
| May 29, 2026 | 2.98 | 3.26 | 2.95 | 3.14 | 277613.0 |
| May 28, 2026 | 3.09 | 3.27 | 3.08 | 3.14 | 169718.0 |
| May 27, 2026 | 3.08 | 3.16 | 3.03 | 3.14 | 145391.0 |
| May 26, 2026 | 3.16 | 3.29 | 3.02 | 3.10 | 187194.0 |
| May 22, 2026 | 3.14 | 3.29 | 3.11 | 3.20 | 145595.0 |
| May 21, 2026 | 3.13 | 3.23 | 3.02 | 3.17 | 146756.0 |
| May 20, 2026 | 3.07 | 3.19 | 2.97 | 3.17 | 314510.0 |
| May 19, 2026 | 3.06 | 3.33 | 3.01 | 3.06 | 521193.0 |
| May 18, 2026 | 3.04 | 3.17 | 2.98 | 3.14 | 249867.0 |
| May 15, 2026 | 3.26 | 3.26 | 2.99 | 3.09 | 216322.0 |
| May 14, 2026 | 2.86 | 3.30 | 2.78 | 3.20 | 412633.0 |
| May 13, 2026 | 2.98 | 3.00 | 2.87 | 2.94 | 179090.0 |
| May 12, 2026 | 2.96 | 3.05 | 2.87 | 2.92 | 240650.0 |
| May 11, 2026 | 2.93 | 3.165 | 2.93 | 3.06 | 317043.0 |
| May 08, 2026 | 3.21 | 3.23 | 2.88 | 3.10 | 687282.0 |
| May 07, 2026 | 3.40 | 3.49 | 3.20 | 3.30 | 618413.0 |
| May 06, 2026 | 3.12 | 3.62 | 2.91 | 3.53 | 1.931M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Karyopharm Therapeutics, Inc. | 9.12 |
| Forum Markets, Inc. | 5.41 |
| ACADIA Pharmaceuticals, Inc. | 21.42 |
| Alnylam Pharmaceuticals, Inc. | 292.01 |
| Savara, Inc. | 5.255 |
Price Related Metrics
| PEG Ratio | -0.0013 |
| Price to Book Value | 3.352 |
| Earnings Yield | -331.4% |
| Market Cap | 9.434M |
| PEGY Ratio | -0.0013 |